Who owns SPDR S&P Pharmaceuticals?
- Ticker: XPH
- CUSIP Number: 78464A722
Tip: Access positions for across all investors
Analyze quarterly positions in SPDR S&P Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of SPDR S&P Pharmaceuticals stock
Who bought or sold SPDR S&P Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Clal Insurance Enterprises Holdings | 800k | $36M | -11% | Sep 2024 |
|
| Bank of America Corporation | 279k | $12M | -9% | Sep 2024 |
|
| Equitable Holdings | 263k | $10M | 100% | Jun 2024 |
|
| Bnp Paribas Arbitrage, Snc | 149k | $6.6M | 209% | Sep 2024 |
|
| Morgan Stanley | 128k | $5.1M | -30% | Jun 2024 |
|
| LPL Financial | 112k | $5.0M | -1% | Sep 2024 |
|
| First Citizens Bank & Trust | 72k | $3.2M | 9% | Sep 2024 |
|
| Wells Fargo & Company | 69k | $3.1M | -4% | Sep 2024 |
|
| Envestnet Portfolio Solutions | 65k | $2.9M | 11% | Sep 2024 |
|
| Susquehanna International | 52k | $2.3M | -27% | Sep 2024 |
|
| Citigroup | 50k | $2.2M | 5000000% | Sep 2024 |
|
| Rockport Wealth | 46k | $1.8M | 100% | Jun 2024 |
|
| Wharton Business Group | 44k | $1.9M | 0% | Sep 2024 |
|
| Goldman Sachs Group | 40k | $1.6M | -74% | Jun 2024 |
|
| MAI Wealth Advisors | 38k | $1.7M | -2% | Sep 2024 |
|
| Citadel Advisors | 36k | $1.6M | 35% | Sep 2024 |
|
| Royal Bank of Canada | 25k | $1.1M | -34% | Sep 2024 |
|
| Pnc Financial Services | 24k | $1.1M | -5% | Sep 2024 |
|
| U.S. Capital Wealth Advisors | 22k | $991k | 24% | Sep 2024 |
|
| Integrated Wealth Concepts | 16k | $727k | -7% | Sep 2024 |
|
| Ameritas Advisory Services | 9.9k | $438k | -7% | Sep 2024 |
|
| Cetera Investment Advisers | 8.8k | $349k | -9% | Jun 2024 |
|
| Concurrent Investment Advisors | 8.1k | $359k | 0% | Sep 2024 |
|
| Raymond James & Associates | 7.6k | $337k | 5% | Sep 2024 |
|
| Commonwealth Equity Services | 7.4k | $330k | 1% | Sep 2024 |
|
| Advisor Group Holdings | 7.2k | $320k | 3% | Sep 2024 |
|
| Two Sigma Investments | 7.2k | $286k | 100% | Jun 2024 |
|
| Fragasso | 6.6k | $293k | -6% | Sep 2024 |
|
| D. E. Shaw & Co | 6.5k | $290k | 100% | Sep 2024 |
|
| Citizens & Northern Corporation | 6.3k | $282k | 100% | Sep 2024 |
|
| AlphaMark Advisors | 6.2k | $276k | 6% | Sep 2024 |
|
| Cambridge Investment Research Advisors | 5.9k | $260k | -3% | Sep 2024 |
|
| Jane Street | 5.8k | $259k | -90% | Sep 2024 |
|
| Captrust Financial Advisors | 5.3k | $236k | 0% | Sep 2024 |
|
| Adviser Investments | 5.0k | $220k | 100% | Sep 2024 |
|
| Janney Montgomery Scott | 4.8k | $213k | -16% | Sep 2024 |
|
| Jpmorgan Chase & Co | 4.4k | $197k | 36% | Sep 2024 |
|
| Atlantic Trust | 2.8k | $123k | 0% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 2.8k | $122k | 6% | Sep 2024 |
|
| Nbc Securities | 2.3k | $103k | 0% | Sep 2024 |
|
| Angeles Wealth Management | 1.0k | $44k | 0% | Sep 2024 |
|
| Whittier Trust | 890.00 | $40k | 0% | Sep 2024 |
|
| Hanson McClain Advisors | 790.00 | $35k | 0% | Sep 2024 |
|
| Northwestern Mutual Wealth Management Company | 712.00 | $32k | -7% | Sep 2024 |
|
| Principal Securities | 613.00 | $27k | 0% | Sep 2024 |
|
| Brian McDonald | 450.00 | $20k | 0% | Sep 2024 |
|
| Custom Portfolio Group | 410.00 | $16k | 0% | Jun 2024 |
|
| Jones Financial Companies, L.L | 403.00 | $18k | 100% | Sep 2024 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $18k | 0% | Sep 2024 |
|
| Lindbrook Capital | 395.00 | $18k | 0% | Sep 2024 |
|
| Castleview Partners | 242.00 | $11k | 0% | Sep 2024 |
|
| CWM | 200.00 | $9.0k | 0% | Sep 2024 |
|
| Advantage Trust | 200.00 | $8.9k | -94% | Sep 2024 |
|
| Addison Advisors | 188.00 | $8.3k | 0% | Sep 2024 |
|
| Qube Research & Technologies | 143.00 | $5.7k | -3% | Jun 2024 |
|
| Global Retirement Partners | 121.00 | $5.4k | 0% | Sep 2024 |
|
| CoreCap Advisors | 73.00 | $3.2k | -15% | Sep 2024 |
|
| Game Plan Financial Advisors | 50.00 | $2.2k | 0% | Sep 2024 |
|
| Arrow Financial Corp. | 50.00 | $2.2k | 0% | Sep 2024 |
|
| Front Row Advisors | 45.00 | $2.0k | 0% | Sep 2024 |
|
| Simplex Trading | 39.00 | $999.999000 | 100% | Sep 2024 |
|
| Goss Wealth Management | 10.00 | $398.000000 | 0% | Jun 2024 |
|
| Creekmur Asset Management | 7.00 | $330.000300 | 0% | Sep 2024 |
|
| Tower Research Capital | 5.00 | $199.000000 | -69% | Jun 2024 |
|
| Huntington National Bank | 1.00 | $44.000000 | 0% | Sep 2024 |
|
Who sold out of SPDR S&P Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Kingsview Wealth Management | Jun 2024 | 149k | $5.9M |
| CX Institutional | Jun 2024 | 9.7k | $386k |
| Stifel Financial | Mar 2024 | 8.9k | $382k |
| Vista Investment Management | Mar 2024 | 5.1k | $221k |
| Great Lakes Retirement | Jun 2024 | 1.4k | $57k |
| New Republic Capital | Jun 2024 | 1.1k | $42k |
| Family Firm | Jun 2024 | 171.00 | $6.8k |
| Cypress Capital | Jun 2024 | 57.00 | $2.3k |